Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
Am J Obstet Gynecol
    April 2025
  1. THEL H, Latour CD, Tsevat D, Dissanayake M, et al
    Prevalence of male and female permanent contraception and long-acting reversible contraceptives among commercially insured US population, 2010-2022.
    Am J Obstet Gynecol. 2025 Apr 18:S0002-9378(25)00230.
    >> Share

    March 2025
  2. MAZZA D, Assifi AR, McGeechan K, Haas M, et al
    Increasing the uptake of long-acting reversible contraception through family practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial 3-year follow-up.
    Am J Obstet Gynecol. 2025 Mar 20:S0002-9378(25)00166.
    >> Share

  3. ALLISON BA, Glodowski CR, Smith C, Mizelle C, et al
    Effectiveness of Interventions to Support Person-Centered Contraceptive Care for Adolescents and Young Adults: A Systematic Review.
    Am J Obstet Gynecol. 2025 Mar 20:S0002-9378(25)00162.
    >> Share

  4. KRASHIN JW, Rivera-Montalvo M, Leeman L, Trujillo VY, et al
    Breastfeeding after immediate versus delayed postpartum contraceptive implant placement: a non-inferiority randomized controlled trial.
    Am J Obstet Gynecol. 2025 Mar 20:S0002-9378(25)00165.
    >> Share

    September 2024
  5. PROVINCIATTO H, Meirelles Dias YJ, Abonizio Magdalena SL, Barbosa Moreira MV, et al
    Immediate versus delayed postpartum insertion of long-acting reversible contraception methods: meta-analysis of randomized controlled trials.
    Am J Obstet Gynecol. 2024 Sep 18:S0002-9378(24)00931.
    >> Share

    August 2024
  6. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
    Effect of Covid-19 pandemic on postpartum depression and contraception.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00843.
    >> Share

  7. RIDGEWELL B, Callins K
    Postpartum depressive symptoms and contraception.
    Am J Obstet Gynecol. 2024 Aug 17:S0002-9378(24)00842.
    >> Share

  8. CHAPPELL CA, Lamorde M, Nakalema S, Kyohairwe I, et al
    A randomized trial of double vs single-dose etonogestrel implant to overcome the interaction with efavirenz-based antiretroviral therapy.
    Am J Obstet Gynecol. 2024;231:242.
    >> Share

    July 2024
  9. SUZUKI Y, Ferris JS, Chen L, Dioun S, et al
    Fertility-preserving Treatment for Stage IA Endometrial Cancer: A Systematic Review and Meta-Analysis.
    Am J Obstet Gynecol. 2024 Jul 18:S0002-9378(24)00761.
    >> Share

  10. RICKER EA, Koltun KJ, DE LA Motte SJ
    Female Service Members Deserve an Individualized Approach to Hormonal Contraception Counseling.
    Am J Obstet Gynecol. 2024 Jul 11:S0002-9378(24)00752.
    >> Share

  11. KINKAID V, Morris K, Guest R
    Hormonal Contraception and Medical Readiness for Female Service Members: A comment.
    Am J Obstet Gynecol. 2024 Jul 11:S0002-9378(24)00751.
    >> Share

  12. KERNS JL, Keder LM, Cwiak CA, Westhoff CL, et al
    Hormone-related side effects in new users of a levonorgestrel 52 mg intrauterine device.
    Am J Obstet Gynecol. 2024 Jul 3:S0002-9378(24)00743.
    >> Share

    June 2024
  13. MILLER CE, Kim JH, Kroll R, Simon JA, et al
    Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: 12 months of an ongoing randomized phase 3 trial.
    Am J Obstet Gynecol. 2024 Jun 30:S0002-9378(24)00731.
    >> Share

    May 2024
  14. RICKER EA, Koltun KJ, de la Motte SJ
    Hormonal Contraception and Medical Readiness for Female Service Members.
    Am J Obstet Gynecol. 2024 May 27:S0002-9378(24)00630.
    >> Share

  15. YI H, Zhang N, Huang J, Zheng Y, et al
    Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden.
    Am J Obstet Gynecol. 2024 May 15:S0002-9378(24)00593.
    >> Share

  16. AMES JL, Anderson MC, Cronbach E, Lee C, et al
    Reproductive healthcare in adolescents with autism and other developmental disabilities.
    Am J Obstet Gynecol. 2024;230:546.
    >> Share

    April 2024
  17. LO FARO V, Johansson A
    Genotyping oral contraceptive users for venous thromboembolism risk.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00565.
    >> Share

  18. VERCELLINI P, Artoni A, Abbattista M, Martinelli I, et al
    PREDICTION OF VENOUS THROMBOEMBOLISM IN AVERAGE-RISK YOUNG CANDIDATES FOR ORAL CONTRACEPTIVE USE: TO GENOTYPE, OR NOT TO GENOTYPE, THAT IS THE QUESTION.
    Am J Obstet Gynecol. 2024 Apr 30:S0002-9378(24)00564.
    >> Share

    March 2024
  19. MATOVINA CN, Sakowicz A, Allen EC, Alvarado-Goldberg MI, et al
    The association between postpartum depressive symptoms and contraception.
    Am J Obstet Gynecol. 2024 Mar 27:S0002-9378(24)00472.
    >> Share

  20. SANCHEZ-RAMOS L, Levine LD, Sciscione AC, Mozurkewich EL, et al
    Methods for the induction of labor: efficacy and safety.
    Am J Obstet Gynecol. 2024;230.
    >> Share

  21. CHESNOKOVA A, Christensen T, Streaty T, McAllister A, et al
    Medicaid compared to private insurance is associated with lower rates of sterilization in people with unwanted births.
    Am J Obstet Gynecol. 2024;230:347.
    >> Share

    February 2024
  22. TORRES E, Carter G, Gero A, Simmons RG, et al
    Frequency of same-day start contraceptive initiation, recent unprotected intercourse, and pregnancy risk: a prospective cohort study of multiple contraceptive methods.
    Am J Obstet Gynecol. 2024 Feb 15:S0002-9378(24)00083.
    >> Share

    January 2024
  23. PLAGIANOS MG, Ramanadhan S, Merkatz RB, Brache V, et al
    Risk Factors for and Outcomes of Ring Expulsions with a One Year Contraceptive Vaginal System.
    Am J Obstet Gynecol. 2024 Jan 29:S0002-9378(24)00061.
    >> Share

  24. HUIJS DPC, Derickx AJM, Beelen P, Leemans JC, et al
    A 52 mg levonorgestrel-releasing intrauterine system versus bipolar radiofrequency non-resectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multi-center randomized controlled trial.
    Am J Obstet Gynecol. 2024 Jan 25:S0002-9378(24)00045.
    >> Share

    December 2023
  25. GUO XM, Lim LM, Matsuzaki S, Matsuo K, et al
    Research on intrauterine manipulators for endometrial cancer: Attention to study-level characteristics.
    Am J Obstet Gynecol. 2023 Dec 8:S0002-9378(23)02122.
    >> Share

    October 2023
  26. DANVERS AA, Gurney EG, Panushka K, Peskin M, et al
    Shortcomings and Disparities in Contraception Counseling and Use by Hypertensive Individuals at Risk for Unintended Pregnancy: A Comparative Analysis of the National Survey of Family Growth 2015-2019.
    Am J Obstet Gynecol. 2023 Oct 21:S0002-9378(23)00768.
    >> Share

    September 2023
  27. LO FARO V, Johansson T, Johansson A
    The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
    Am J Obstet Gynecol. 2023 Sep 19:S0002-9378(23)00618.
    >> Share

    August 2023
  28. MATTESON KA, Valcin J, Raker CA, Clark MA, et al
    A randomized trial comparing the 52-mg levonorgestrel system to combination oral contraceptives for treatment of heavy menstrual bleeding.
    Am J Obstet Gynecol. 2023 Aug 1:S0002-9378(23)00521.
    >> Share

    July 2023
  29. EASTIN EF, Nelson DA, Shaw JG, Shaw KA, et al
    Postpartum long-acting reversible contraceptive use among active-duty, female U.S. Army soldiers.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00471.
    >> Share

  30. CATHCART AM, Nezhat FR, Fitch KC, Nguyen CGT, et al
    Trends in permanent contraceptive procedural volume in the United States between 2019 and 2020.
    Am J Obstet Gynecol. 2023 Jul 15:S0002-9378(23)00467.
    >> Share

  31. CREININ MD, Jensen JT
    Extending use of levonorgestrel 52 mg intrauterine device to 8 years.
    Am J Obstet Gynecol. 2023;229:84.
    >> Share

  32. GOLDBERG AB
    Extending the use of levonorgestrel 52 mg intrauterine devices to 8 years.
    Am J Obstet Gynecol. 2023;229:85.
    >> Share

    June 2023
  33. SWAN LET, Cutler AS, Higgins JA
    Response to Letter to the Editor Regarding Physician Beliefs about Contraceptives as Abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00412.
    >> Share

  34. BEITER KA, Stanford JB
    Contraceptives as abortifacients.
    Am J Obstet Gynecol. 2023 Jun 15:S0002-9378(23)00411.
    >> Share

    April 2023
  35. EDELMAN A, Boniface E, Schrote K, Messerle-Forbes M, et al
    Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00265.
    >> Share

    March 2023
  36. PHILLIPS AM, Rachad S, Flink-Bochacki R
    The association between abortion restrictions and patient-centered care for early pregnancy loss at U.S. OB/GYN residency programs.
    Am J Obstet Gynecol. 2023 Mar 30:S0002-9378(23)00223.
    >> Share

  37. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    >> Share

  38. ZHANG J, Zhu C, Yan L, Wang Y, et al
    Comparing levonorgestrel intrauterine system versus hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open label, controlled trial.
    Am J Obstet Gynecol. 2023 Mar 17:S0002-9378(23)00167.
    >> Share

  39. LEVINE EM
    Extended use of the Levonorgestrel Intrauterine System for Contraception.
    Am J Obstet Gynecol. 2023 Mar 16:S0002-9378(23)00160.
    >> Share

  40. THURMAN AR, Moench TR, Hoke M, Politch JA, et al
    ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study.
    Am J Obstet Gynecol. 2023 Mar 2:S0002-9378(23)00139.
    >> Share

    December 2022
  41. HEALY A, Davidson C, Allbert J, Bauer S, et al
    Telemedicine in obstetrics, quality and safety considerations.
    Am J Obstet Gynecol. 2022 Dec 5:S0002-9378(22)02261.
    >> Share

    October 2022
  42. FELS LM, Costescu D, Vieira CS, Peipert JF, et al
    The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
    Am J Obstet Gynecol. 2022 Oct 29:S0002-9378(22)00835.
    >> Share

    June 2022
  43. NAGENDRA D, Gutman SM, Koelper NC, Loza-Avalos SE, et al
    Medical management of early pregnancy loss is cost-effective compared to office uterine aspiration.
    Am J Obstet Gynecol. 2022 Jun 30. pii: S0002-9378(22)00530.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016